1. Home
  2. KLRA vs STDN Comparison

KLRA vs STDN Comparison

Compare KLRA & STDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$11.57

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Standard Nuclear Inc. Class A Common Stock

STDN

Standard Nuclear Inc. Class A Common Stock

N/A

Current Price

$8.99

Market Cap

1.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
KLRA
STDN
Founded
2024
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2026
2026

Fundamental Metrics

Financial Performance
Metric
KLRA
STDN
Price
$11.57
$8.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
★ $43.00
$16.88
AVG Volume (30 Days)
★ 780.6K
251.9K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$460.20
Revenue Next Year
N/A
$249.04
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.76
$7.05
52 Week High
$23.82
$17.34

Technical Indicators

Market Signals
Indicator
KLRA
STDN
Relative Strength Index (RSI) 40.01 30.24
Support Level $9.76 $7.05
Resistance Level $11.81 $13.61
Average True Range (ATR) 1.01 1.05
MACD -0.18 -0.34
Stochastic Oscillator 5.26 3.12

Price Performance

Historical Comparison
KLRA
STDN

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

About STDN Standard Nuclear Inc. Class A Common Stock

Standard Nuclear Inc is an independent advanced nuclear fuel company. The company designs, engineers, and manufactures advanced nuclear fuels, with a primary focus on TRISO fuel for advanced reactors. Its operations include industrial-scale TRISO fuel manufacturing and the development of fuel for advanced reactors that utilize TRISO fuel. The company operates in a single operating and reportable segment, as it is engaged in a single business activity of TRISO production. It derives revenue from fuel development and services agreements. Geographically, the maximum revenue is generated from the United States.

Share on Social Networks: